Literature DB >> 632595

DNA synthesis and proliferation of human lymphocytes in vitro. I. Cell kinetics of response to phytohemagglutinin.

J L Bernheim, R E Dorian, J Mendelsohn.   

Abstract

The response of human lymphocytes to phytohemagglutinin (PHA) stimulation was assessed in detailed kinetic studies, in order to define conditions permitting and regulating proliferation. By utilizing live and dead cell counts, cell cycle characterizations, and calculations of rates of entry into S phase and mitosis, it was demonstrated that dilute culture conditions (2 X 10(5) cells/ml) enable lymphocytes to proliferate for a period of 5 or 6 days. Although cell division occurs in concentrated cultures (2 X 10(6) cells/ml), net proliferation is not demonstrable due to extensive cell death and earlier decay in the proliferative response. It is projected that without cell death the cell count would rise more than 6-fold in a dilute culture and 2-fold in a concentrated culture under these growth conditions. The kinetic analyses did not demonstrate separate PHA dose thresholds for blastogenesis and entry into S phase. High doses of PHA stimulated a suboptimal response by causing excessive cell death without reducing initial entry into the cell cycle. These results provide a kinetic explanation for the frequent observation of little net proliferation despite substantial 3H-thymidine incorporation in PHA-stimulated lymphocyte cultures. Cell death is identified as a parameter that must be considered in the interpretation of in vitro lymphocyte stimulation studies, and methods for quantifying the role of cell death are demonstrated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632595

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes.

Authors:  W Shive; F Pinkerton; J Humphreys; M M Johnson; W G Hamilton; K S Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.

Authors:  J S Goodwin; R P Messner
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Relationship between RNA content and progression of lymphocytes through S phase of cell cycle.

Authors:  Z Darzynkiewicz; D Evenson; L Staiano-Coico; T Sharpless; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 4.  Cellular and molecular aspects of immune system aging.

Authors:  D L Doggett; M P Chang; T Makinodan; B L Strehler
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

5.  Optimal conditions in [3H]-thymidine uptake studies to prevent radiation damage to cells. A scintimetric and cytofluorographic analysis.

Authors:  A Ruiz-Arguelles; L Llorente; E Díaz-Jouanen; D Alarcón-Segovia
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

6.  Reduced rate of DNA replication fork movement in megaloblastic anemia.

Authors:  R G Wickremasinghe; A V Hoffbrand
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

7.  Induction of unresponsiveness to major transplantable organs in adult mammals: a recapitulation of ontogeny by irradiation and bone marrow replacement.

Authors:  F T Rapaport; R J Bachvaroff; N Mollen; H Hirasawa; T Asano; J W Ferrebee
Journal:  Ann Surg       Date:  1979-10       Impact factor: 12.969

8.  Radiation protection of stimulated human lymphocytes by nicotinamide.

Authors:  R Kol; E Ben-Hur
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

9.  An updated view into the cell cycle kinetics of human T lymphocytes and the impact of irradiation.

Authors:  Evi Duthoo; Anne Vral; Ans Baeyens
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

10.  Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.

Authors:  Annelot Baert; Julie Depuydt; Tom Van Maerken; Bruce Poppe; Fransiska Malfait; Katrien Storm; Jenneke van den Ende; Tim Van Damme; Sylvia De Nobele; Gianpaolo Perletti; Kim De Leeneer; Kathleen B M Claes; Anne Vral
Journal:  Breast Cancer Res       Date:  2016-05-17       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.